Limba
|
Atamparib (RBN-2397) is a potent, selective and orally active NAD+ competitive inhibitor PARP7with IC50 of <3 nM and Kd of <0.001 μM. RBN-2397 has the potential for the research of tumor treatment.
Price | 21.656,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Atamparib (RBN-2397) is a potent, selective and orally active NAD+ competitive inhibitor PARP7with IC50 of <3 nM and Kd of <0.001 μM. RBN-2397 has the potential for the research of tumor treatment. |